What is Cholesterol Screening Market Scope?
Cholesterol is a waxy, fat-like substance that is found in all cells in our body. If there is too much cholesterol present in the blood, it can further combine with other substances in the blood thus forming plaque that adheres to the walls of the arteries. A full cholesterol test is also known as a lipid panel or lipid profile. A full cholesterol test measures four types of lipids, or fats, in the blood, total cholesterol is therefore the total amount of cholesterol present in the blood. Low-density lipoprotein (LDL) cholesterol is generally known to be as bad cholesterol. A high amount of bad cholesterol increases your risk of heart attack, stroke, and atherosclerosis. Cholesterol screening services enable the early detection of problems related to high cholesterol, avoid complications, and increase patient survival. According to the population department of the Ministry of Economic and Social Affairs, the world population aged 60 and over was around 11.7% in 2013 and is expected to increase further to 21.1% by 2050. According to data that was released by the United Health Foundation in 2017, around 12.5% of people who were aged 60 and over had high levels of total cholesterol. Such a high prevalence is hence expected to drive market growth in the near future.
The Cholesterol Screening market study is being classified by Type (Product [Test Kits, Testing Strips, Devices] and Services), by Application (Clinics, Hospitals, Ambulatory Centers, Homecare and Diagnostic Centers) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Cholesterol Screening market throughout the predicted period.
ACM Medical Laboratory (United States), Clinical Reference Laboratory (CRL) (United States), Unilabs (Switzerland), Laboratory Corporation of America (LabCorp) (United States), Eurofins Scientific (Luxembourg), Quest Diagnostics Incorporated (United States), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (United States) and Fresenius Medical Care Holdings, Inc. (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Spectra Laboratories Inc. (United States) and Adicon Clinical Laboratory (China).
Analyst at AMA have segmented the market study of Global Cholesterol Screening market by Type, Application and Region.
On the basis of geography, the market of Cholesterol Screening has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In 2017, Quest Diagnostics had thereby introduced a novel, non-fasting cholesterol testing with an improved LDL calculation method for the means of improved accuracy as well as patient comfort.
Influencing Market Trend
- Growing Number of Testing Facilities in the Developing Regions
- Rise In Public Awareness about the Cardiovascular Disease, Its Causes, Treatment, and Prevention
- Increase in Incidence of Cardiovascular Diseases and Obesity
- A Rapid Growth in Sedentary Lifestyle
- Increasing Awareness Regarding Routine Screening of Cholesterol Level
- Rise in Geriatric Population Offering a Large Patient Pool
- Government Initiatives for Better Healthcare Services
- Increase in Healthcare Expenditure
- Government Initiatives to Improve Quality of Testing
- Swift Growth in Self-Testing Devices
- The Advent of Noninvasive Cholesterol Testing Approaches
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Providers of Cholesterol Screening, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.